Xconomy: Agenda: Seattle's Life Science Disruptors

Agenda: Seattle’s Life Science Disruptors


	5.2.2016	AGENDA
		.
	12:30 – 1:30	Registration & Networking
	1:30 – 1:40	Welcome Nicole Robinson, Fred Hutchinson Cancer Research Center Jim Edwards, Xconomy
	1:40 – 2:00	Update From The Immuno-Oncology Trenches Rob Hershberg, Celgene
	2:00 – 2:15	CD19 CAR-T Cell Immunotherapy: A Case Study Cameron Turtle, Fred Hutchinson Cancer Research Center
	2:15 – 2:30	Immunotherapy Beyond Cancer Andrew Scharenberg, Seattle Children’s Research Institute
	2:30 – 2:55	Wellness and Prevention, 21st Century Priorities Clayton Lewis, Arivale Molly Moore, Cambia Health Solutions Alex Lash, Xconomy (moderator)
	2:55 – 3:25	From AIDS To Zika, Combating Global Health Crises Jennifer Dent, BIO Ventures for Global Health Larry Corey, HIV Vaccine Trials Network, Fred Hutchinson Cancer Research Center Jim Thomas, Just Biotherapeutics Rhea Coler, Infectious Disease Research Institute
	3:25 – 4:00	Networking Break
	4:00 – 4:25	Sharing Data For Better Health Stephen Friend, Sage Bionetworks Matthew Trunnell, Fred Hutchinson Cancer Research Center *Panel Moderated by:* Austin Walsh, IBM
	4:25 – 4:40	The State Of Seattle Startups Thong Le, Accelerator In conversation with Alex Lash, Xconomy
	4:40 – 5:00	M3 Biotechnology: A Founder-Investor Story Leen Kawas, M3 Biotechnology John Fluke, Fluke Capital Management Alex Lash, Xconomy (moderator)
	5:00 – 5:30	Proteins Like You’ve Never Seen David Baker, University of Washington Aaron Chevalier, Virvio Lucas Nivon, Cyrus Biotechnology Ingrid Swanson Pultz, PVP Biologics Alex Lash, Xconomy (moderator)
	5:30 – 6:30	Networking Reception